<DOC>
	<DOCNO>NCT00537446</DOCNO>
	<brief_summary>Amyotrophic Lateral Sclerosis ( ALS ) , `` Lou Gehrig 's Disease '' , fatal disorder cause progressive degeneration weaken muscle breathe , lead breathe insufficiency eventually breathing failure . This breathing insufficiency commonly treat breathe assistance device , know noninvasive positive pressure ventilation ( NIPPV ) . While generally well tolerate accept , clear whether extent NIPPV fact help breathe function : data suggest NIPPV preserve breathe function time , whereas data suggest actually cause breathe function decline quickly . No study show acute effect NIPPV breathing muscle function ALS patient . This study test hypothesis acute use NIPPV , pressure level common clinical use , cause measurable change test breathe function , compare baseline low level NIPPV . We expect result study help clarify whether extent NIPPV assist respiratory muscle function patient ALS .</brief_summary>
	<brief_title>Effect Noninvasive Ventilation Lung Function Amyotrophic Lateral Sclerosis</brief_title>
	<detailed_description />
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Motor Neuron Disease</mesh_term>
	<mesh_term>Amyotrophic Lateral Sclerosis</mesh_term>
	<criteria>clinical diagnosis amyotrophic lateral sclerosis clinical indication start noninvasive ventilation ( forced vital capacity &lt; 50 % predict signs/symptoms respiratory insufficiency ) age 18 80 year old prior institution NIPPV inability safely use NIPPV indication tracheostomy assist ventilation inability clear secretion airway inability unwillingness perform pulmonary function test presence advance dementia .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2011</verification_date>
	<keyword>noninvasive ventilation</keyword>
</DOC>